None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Men and women, 39 to 65 years old 2. Systolic blood pressure between 120 and 159mmHg and/or diastolic blood pressure between 80 and 99mmHg as measured in a sitting position 3. The absence of objective signs of hypertension end-stage disease
Exclusion criteria
Exclusion criteria: 1. Taking medicine for blood pressure control, such as prescription or OTC medication or herb/supplement 2. Stage II hypertension 3. Previous cerebrovascular or heart disease such as myocardial infarction, angina and valvular disease 4. Wasting disease 5. Insulin or diabetes medication in diabetic patients 6. Previous kidney, liver or hyperthyroidism 7. Active tuberculosis and other infectious disease 8. Systemic steroids or immunosuppressive therapy 9. Oral contraceptives, central nervous system inhibitors or stimulants, such as taking medication that affects blood pressure 10. Pregnant women, lactating and pregnant women who plan on 11. Others whose clinical trials conductors are considered inappropriate for participating in this trial
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change of blood pressure | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of Life (EQ5D, MYMOP2);lipid profile | — |
Countries
Korea, Republic of
Contacts
Korea Institute of Oriental Medicine